These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23252745)

  • 1. Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.
    Sosič I; Mirković B; Arenz K; Stefane B; Kos J; Gobec S
    J Med Chem; 2013 Jan; 56(2):521-33. PubMed ID: 23252745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B inhibitors: Further exploration of the nitroxoline core.
    Sosič I; Mitrović A; Ćurić H; Knez D; Brodnik Žugelj H; Štefane B; Kos J; Gobec S
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1239-1247. PubMed ID: 29503024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion.
    Mitrović A; Mirković B; Sosič I; Gobec S; Kos J
    Biol Chem; 2016 Jan; 397(2):165-74. PubMed ID: 26565553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
    Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
    J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
    Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
    J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.
    Katunuma N; Matsui A; Inubushi T; Murata E; Kakegawa H; Ohba Y; Turk D; Turk V; Tada Y; Asao T
    Biochem Biophys Res Commun; 2000 Jan; 267(3):850-4. PubMed ID: 10673380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis.
    Lim IT; Meroueh SO; Lee M; Heeg MJ; Mobashery S
    J Am Chem Soc; 2004 Aug; 126(33):10271-7. PubMed ID: 15315439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.
    Premzl A; Zavasnik-Bergant V; Turk V; Kos J
    Exp Cell Res; 2003 Feb; 283(2):206-14. PubMed ID: 12581740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.
    Mirković B; Renko M; Turk S; Sosič I; Jevnikar Z; Obermajer N; Turk D; Gobec S; Kos J
    ChemMedChem; 2011 Aug; 6(8):1351-6. PubMed ID: 21598397
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
    Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
    Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
    Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
    Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B.
    Pan X; Tan N; Zeng G; Zhang Y; Jia R
    Bioorg Med Chem; 2005 Oct; 13(20):5819-25. PubMed ID: 16084098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity.
    Mitrović A; Kljun J; Sosič I; Uršič M; Meden A; Gobec S; Kos J; Turel I
    Inorg Chem; 2019 Sep; 58(18):12334-12347. PubMed ID: 31464130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
    Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
    Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents.
    Ettari R; Pinto A; Tamborini L; Angelo IC; Grasso S; Zappalà M; Capodicasa N; Yzeiraj L; Gruber E; Aminake MN; Pradel G; Schirmeister T; De Micheli C; Conti P
    ChemMedChem; 2014 Aug; 9(8):1817-25. PubMed ID: 24919925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
    van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
    J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.
    Gunatilleke SS; Barrios AM
    J Med Chem; 2006 Jun; 49(13):3933-7. PubMed ID: 16789749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.